Here are seven articles Becker's Hospital Review published in the last week, highlighting California's new drug price transparency law and the state of drug manufacturing operations in hurricane-damaged Puerto Rico, among other topics.
1. This startup will deliver defibrillators to 911 callers via drone
Reno, Nev.-based tech startup Flirtey is developing a drone service that delivers portable defibrillators to local 911 callers who report symptoms of cardiac arrest.
2. Dr. Scott Gottlieb: Hospitals could see drug shortages in 2 to 3 weeks
The U.S. could see several drug shortages within the next two to three weeks due to manufacturing issues in Puerto Rico, according to Scott Gottlieb, MD, head of the Food and Drug Administration.
3. Amazon will decide on drug market entry by Thanksgiving
Amazon will decide whether to enter the U.S.'s multibillion-dollar prescription drug market before Thanksgiving.
4. J&J exits insulin pump business: 4 things to know
Johnson & Johnson's insulin pump unit, Animas Corp., will shutter business operations in the U.S. and Canada, effective immediately.
5. Medtronic estimates $250M earnings loss from Hurricane Maria: 4 things to know
Medtronic expects supply chain disruptions caused by Hurricane Maria to cost the company up to $250 million in the second quarter of fiscal year 2018, which ends Oct. 27.
6. Pfizer contemplates sale, spinoff of consumer health unit
Pfizer may spin off or sell its consumer healthcare division.
7. California governor defies drug lobby, inks law requiring pharma to justify price hikes
California Gov. Jerry Brown signed a drug price transparency bill into law Monday, which forces drugmakers to publicly justify price hikes in the state.
More articles on supply chain:
Express Scripts to acquire eviCore for $3.6B: 4 things to know
This startup will deliver defibrillators to 911 callers via drone
4 drug, devicemakers in the headlines